SCHEMBL6749276

SCHEMBL6749276

O=C(O)C1[CH]CC12CCN(Cc1ccccc1)CC2

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CHRM2 P08172 3/20 0.50
OPRL1 P41146 1/20 0.50
CHRM3 P20309 1/20 0.50
CYP3A4 P08684 4/20 0.49
POLB P06746 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TSHR P16473 2/20 0.48
HRH3 Q9Y5N1 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
ALDH1A1 P00352 3/20 0.47
USP2 O75604 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.46
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143509 0.75 CYP2D6 (0.52) CYP2D6L3MBTL1CHRM2OPRL1CHRM3
SCHEMBL6750542 0.74 OPRM1 (0.54) CYP2D6OPRL1CYP3A4POLBHSD17B10
SCHEMBL23145284 0.74 ACHE (0.53) CYP2D6CHRM2OPRL1CHRM3CYP3A4
SCHEMBL6749273 0.74 CYP2D6 (0.61) CYP2D6L3MBTL1CHRM2OPRL1CHRM3
SCHEMBL16862697 0.72 CYP2D6 (0.56) CYP2D6CHRM2OPRL1CHRM3CYP3A4
SCHEMBL1147211 0.72 OPRL1 (0.63) CYP2D6CHRM2OPRL1CHRM3CYP3A4
SCHEMBL28548988 0.71 OPRL1 (0.71) CYP2D6CHRM2OPRL1CHRM3CYP3A4
SCHEMBL1269458 0.71 CYP2D6 (0.61) CYP2D6CHRM2OPRL1CHRM3CYP3A4
SCHEMBL1975609 0.71 CYP2D6 (0.57) CYP2D6CHRM2OPRL1CHRM3CYP3A4
Hydrochloric Acid SCHEMBL25235306 0.71 POLB (0.64) CYP2D6CHRM2OPRL1CHRM3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092737-A1 Benzopiperidine derivatives HLA-DRB1, HRH1, HRH2 CYP2D6 32/4885L3MBTL1 4411/4885CHRM2 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.